Dr. David Kaufman & Paddy Monahan on Vindara Health for Complex Patients

Vindara Health is the new telehealth specialty clinic created by Dr. David Kaufman and Paddy Monahan, to improve access to expert care for patients with the most complex conditions, including POTS, long COVID, ME/CFS, MCAS, autoimmunity, Lyme, fibromyalgia and more.  In this episode they discuss how it works, why they were inspired to create a new model, why they think there is increasing complex chronic illness, why working within the standard medical system is so limiting when treating complex chronic illness, and what research and treatments they are most excited about currently.  They also mention they are hiring providers. Links to mentioned resources: Dr. Kaufman's article on the use of low-dose rapamycin for fatigue and post-exertional malaise in ME/CFS Dr. Kaufman's presentation at Stanford University's Community Symposium on the Molecular Basis of ME/CFS on 9/11/26:  Rebooting the System: mTOR, Autophagy, and Low Dose Rapamycin (link to video will be added when it gets released). Case report on amlexanox helping a few patients with MCAS. If you liked this episode, we hope you will click subscribe so that you don't miss an episode. If you are so moved, donations are accepted to help to support our production costs  https://www.standinguptopots.org/donate Tell us what you think of The POTScast or send us your idea at info@standinguptopots.org! Find out more about Standing Up to POTS! Check us out on our Website: www.standinguptopots.org Facebook: https://www.facebook.com/standinguptopots/ Instagram: https://www.instagram.com/standinguptopots/ X: https://twitter.com/POTSActivist Medical Disclaimer: The information provided here is not intended to serve as professional medical advice, diagnosis, or treatment. If you have health related issues, please contact a qualified health professional to get the personalized assessment, advice, and treatment that you need. Standing Up to POTS will not be liable for any direct, indirect, or other damages arising from the use of this podcast.